Lawrence Alan Teplin, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 909 San Ramon Valley Blvd, Ste. 118, Danville, CA 94526 Phone: 925-362-1080 Fax: 925-362-1083 |
Lawrence A Teplin Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 909 San Ramon Valley Blvd, Suite #118, Danville, CA 94526 Phone: 925-362-1080 Fax: 925-362-1083 |
Camarda Foot Clinic, Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 43 Pulido Ct, Danville, CA 94526 Phone: 925-820-7492 Fax: 925-820-9022 |
Dr. Judianne Marguriette Walker, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1320 El Capitan Ste 410, Danville, CA 94526 Phone: 925-830-2929 Fax: 925-830-4770 |
Bay Area Foot Care, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1320 El Capitan Dr Ste 450, Danville, CA 94526 Phone: 925-830-2929 Fax: 925-830-4770 |
Dr. Donald Joseph Camarda, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 43 Pulido Ct, Danville, CA 94526 Phone: 925-820-7492 Fax: 925-820-9022 |
Jeffery Gregori, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1320 El Capitan Dr Ste 450, Danville, CA 94526 Phone: 510-581-1484 |
Judianne Walker D.p.m. Corp. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1320 El Capitan Dr, #410, Danville, CA 94526 Phone: 925-830-2929 Fax: 925-830-4770 |
News Archive
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
University of Alberta researcher Flora Wang found that a diet with enriched levels of trans vaccenic acid (VA) - a natural animal fat found in dairy and beef products - can reduce risk factors associated with heart disease, diabetes and obesity
Nonetheless, experts say California's online marketplace increased competition in the state's individual market. Meanwhile, lower-than-expected enrollment in Oregon creates budget issues, and a Democratic congresswoman from Arizona calls on the administration to extend the enrollment deadline past April 15.
Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients' conditions. The ongoing clinical study shows the treatment's best case could reconstruct a patient's natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to return to the normal activities non-diabetes sufferers take for granted.
› Verified 3 days ago